Ocular in Situ Gel: Development, Evaluation, and Advancement

In situ gel refers to a gel that forms when a solution is placed in the eye. The solution undergoes a transformation, typically from a liquid to a gel, in response to environmental conditions (like temperature, pH, or ionic strength). This helps the drug stay in place longer, improving its effectiveness by allowing for sustained release. Antibacterial ophthalmic. This means the formulation is designed for the eye and contains antibacterial agents that target eye infections. These agents are usually intended to treat or prevent bacterial infections like conjunctivitis or corneal ulcers. Such formulations are typically designed to offer controlled drug release, which can improve patient compliance and reduce side effects compared to traditional eye drops. The gel helps the drug remain in contact with the ocular surface for an extended period, while the antibacterial properties target pathogens that may cause infections.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-22
DOI
https://doi.org/10.5281/zenodo.15258489
Primary Topic
Ocular Diseases and Behçet’s Syndrome
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ocular in Situ Gel: Development, Evaluation, and Advancement

Zenodo (CERN European Organization for Nuclear Research)
Ocular Diseases and Behçet’s Syndrome
article

Ocular in Situ Gel: Development, Evaluation, and Advancement

article en

Abstract

In situ gel refers to a gel that forms when a solution is placed in the eye. The solution undergoes a transformation, typically from a liquid to a gel, in response to environmental conditions (like temperature, pH, or ionic strength). This helps the drug stay in place longer, improving its effectiveness by allowing for sustained release. Antibacterial ophthalmic. This means the formulation is designed for the eye and contains antibacterial agents that target eye infections. These agents are usually intended to treat or prevent bacterial infections like conjunctivitis or corneal ulcers. Such formulations are typically designed to offer controlled drug release, which can improve patient compliance and reduce side effects compared to traditional eye drops. The gel helps the drug remain in contact with the ocular surface for an extended period, while the antibacterial properties target pathogens that may cause infections.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 41%
Ocular Diseases and Behçet’s Syndrome
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.